Assessment of Pathogenicity of Community-Acquired MRSA Isolates in Mice-Induced Peritonitis
Main Article Content
Abstract
Introduction: Methicillin-Resistance Staphylococcus aureus (MRSA) is known as a major nosocomial pathogen in healthcare. However, it has now spread in the community known as community-acquired MRSA (CA-MRSA). Thus, the survival and pathogenicity of CA-MRSA isolates were assessed using in vivo peritonitis model with comparison to ATCC-MRSA. Two CA-MRSA isolates; CA-MRSA1 and CA-MRSA2 that were isolated from healthy population, were studied and compared. Methods: Mice were assigned into 4 groups and injected intraperitoneally with ATCC-MRSA, CA-MRSA1 or CA-MRSA2, respectively. Sterile Dulbecco’s Phosphate-Buffered Saline (DPBS) represents negative control. Mice were observed twice daily, 0-72 hours of post-infection. Any signs of distress were recorded for severity score and survival analyses. Mice were euthanised at 72 hours post-inoculation or by referring to the Peritonitis Severity Scoring (PSS) system. Organs of interest, peritoneal lavage and abscess were processed for bacterial counts. Tissue samples were analysed for histopathological scores. Results: All mice inoculated with MRSA showed clear signs of illness with peritonitis symptoms of p<0.001 and comparable PSS scores were recorded in all infected mice groups. Intraperitoneal injection of lethal dose of MRSA resulted in significant death of ATCC-MRSA (p<0.05) and CA-MRSA-infected mice (p<0.01), compared to the un-infected. Bacterial burden was significantly high in all samples harvested from mice challenged with CA-MRSA2 compared to ATCC-MRSA except in abscess and lung. Significant liver necrosis and spleen inflammation were observed in CA-MRSA1, and lung inflammation in ATCC-MR- SA-infected mice. Conclusion: Nasal carriage CA-MRSA isolates from a healthy population has the potential to cause peritonitis with comparable severity as ATCC-MRSA.
Downloads
Article Details
References
Rasmussen RV, Jr VGF, Skov R, Bruun NE. Future challenges and treatment of Staphylococcus aureus bacteremia with emphasis on MRSA. Future Microbiology. 2011; 6(1): 43-56.
Batabyal B, Kundu GKR, Biswas S. Methicillin- resistant Staphylococcus aureus: a brief review. International Research Journal of Biological Sciences. 2012; 1(7): 65-71.
David MZ, Glikman D, Crawford SE, Peng J, King KJ, Hostetler MA, Boyle-Vavra S, Daum RS. What is community-associated methicillin-resistant Staphylococcus aureus. The Journal of Infectious Diseases. 2010; 197(9): 1235-1243.
Huang H, Flynn NM, King JH, Monchaud C, Morita M, Cohen SH. Comparisons of community- associated methicillin-resistant Staphylococcus aureus (MRSA) and hospital-associated MRSA infections in Sacramento, California. Journal of Clinical Microbiology. 2006; 44(7): 2423–2427.
Choo. Community-associated methicillin resistant Staphylococcus aureus in nosocomial infections. Infection and Chemotherapy. 2017; 49(2): 158-159.
Green BN, Johnson CD, Egan JT, Rosenthal M, Griffith EA, Evans MW. (2010). Methicillin resistant Staphylococcus aureus: an overview for manual therapists. Journal of Chiropractic Medicine. 2010; 11(1): 64-76.
Kumari J, Shenov SM, Baliqa S, Chakrapani M, Bhat GK. Healthcare-associated methicillin resistant Staphylococcus aureus clinical characteristics and antibiotic profile with emphasis on macrolide- lincosamidestreptogramin B resistance. Sultan Qaboos University Medical Journal. 2016; 16(2): 175-181
Tokajian S. New epidemiology of Staphylococcus aureus infections in the Middle East. Clinical Microbiology and Infections. 2014; 20(7): 624-628.
Figueiredo AE, Siqueira SL, Poli-de-Figueiredo CE, d'Avila DO. (2013). Peritoneal dialysis patients: a comparison of two techniques. Peritoneal Dialysis International. 2013; 33: 655–661.
Battelino N, Pokorn M, vent‐Kučina N, Križan‐ Hergouth V, Novljan G. Fulminant peritonitis presumably caused by Panton‐Valentine Leukocidin positive Staphylococcus aureus in a girl on peritoneal dialysis. Therapeutic Apheresis and Dialysis. 2013; 17(4): 431-437
Prasad S, Nayak N, Satpathy G, Nag HL, Venkatesh P, Ramakrishnan S. Molecular & phenotypic characterization of Staphylococcus epidermidis in implant related infections. Indian Journal of Medical Research. 2012; 136(3): 483–490.
Ong LM, Ch’Ng CC, Wee HC, Supramaniam P, Zainal H, Goh BL, Bavanandan S, Mushahar L, Hooi LS, Ahmad G. Risk of peritoneal dialysis-related peritonitis in a multi-racial Asian population. Peritoneal Dialysis International. 2017; 37(1): 35–43.
Gordon RJ, Lowy FD. Pathogenesis of methicillin- resistant Staphylococcus aureus infection. Clinical Infectious Disease. 2008; 10032(5): 350-359.
Govindarajulu S, Hawley CM, Mcdonald SP, Brown FG, Johan B, Wiggins KJ, Bannyster KM, Johnson DW. Staphylococcus aureus peritonitis in Australian peritoneal dialysis. Peritoneal Dialysis International. 2010; 30: 311–319.
Kreft B, Eckstein S, Kahl A, Frei U, Witte W, Trautmann M. Clinical and genetic analysis of Staphylococcus aureus nasal colonisation and exit-site infection in patients undergoing peritoneal dialysis. European Journal Clinical Microbiology. 2001; 20(10): 734–737.
Tong SY, Davis JS, Eichenberger E, Holland TL, Fowler VG, Jr. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management. Clinical Microbiology Reviews. 2015; 28(3): 603–661
Wanten GJ, Van Oost P, Schneeberger PM, Koolen MI. Nasal carriage and peritonitis by Staphylococcus aureus in patients on continuous ambulatory peritoneal dialysis: a prospective study. Peritoneal Dialysis International. 1996; 16:352-356.
Mat Azis N, Hamid AB, Pung HP, 'Amirah P, Rafee A, Yahya FA, Nordin SA, Neela V, Suhaili Z, Mohd Desa MN. Staphylococcus aureus infection risk in a population of health sciences students at a public university. Iranian Journal of Public Health. 2015; 43 (3): 112-116.
Suhaili Z, Johari SA, Sajili MH, Yahya A, Zakaria ZA, Mohd Desa MN, Ali AM. In silico PCR verification and simplex real-time PCR detection of methicillin-resistant Staphylococcus aureus (MRSA) from east coast Malaysian clinical isolates. Walailak Journal of Science and Technology. 2013; 10(3): 237-246
Shrum B, Anantha RV, Xu SX, Donnelly M, Haeryfar SMM, McCormick JK, & Mele T. A robust scoring system to evaluate sepsis severity in an animal model. BMC Research Notes. 2014; 47 (233): 1-11.
Meurer SK, Neß M, Weiskirchen S, Kim P, Tag CG, Kauffmann M, Huber M, Weiskirchen R. Isolation of mature (peritoneum-derived) mast cells and immature (bone marrow-derived) mast cell precursors from mice. PLos One. 2016; 6 (11):116.
Otto M. Community-associated MRSA: what makes them special?. International Journal of Medical Microbiology: IJMM. 2013; 303 (0): 324-330.
Kock R, Siam K, Al-Malat S, Christmann J, Schaumburg F, Becker K, Friedrich AW. Characteristics of hospital patients colonized with livestock associated methicillin-resistant Staphylococcus aureus (MRSA) CC398 versus other MRSA clones. Journal of Hospital Infection. 2011;79:292-296.
Rauch S, DeDent AC, Kim HK, Wardenburg JB, Missiakas DM, Schneewind O. Abscess formation and alpha-hemolysin induced toxicity in a mouse model of Staphylococcus aureus peritoneal infection. Infection and Immunity. 2013; 80(10), 3721–3732.
Kockritz-Blickwede VM, Rohde M, Oehmcke S, Miller LS, Cheung AL, Herwald H, Foster S, Medina
E. Immunological mechanisms underlying the genetic predisposition to severe Staphylococcus aureus infection in the mouse model. American Journal of Pathology. 2008; 173(6):1657-1668.
Jang HC, Kang SJ, Choi SM, Park KH, Shin JH, Choy HE, Jung SI, Kim HB. Difference in agr dysfunction and reduced Vancomycin susceptibility between MRSA bacteremia involving SCCmec Types IV/IVa and I-III. PLoS One. 2012; (11): e49136.
Robinson DA, Kearns AM, Holmes A, Morrison D, Grundmann H, Edwards G, O'Brien FG, Tenover FC, McDougal LK, Monk AB, Enright MC. Re- emergence of early pandemic Staphylococcus aureus as a community-acquired meticillin- resistant clone. Lancet. 2005; 365: 1256-1258.
DeLeo FR, Otto M, Kreiswirth BN, Chambers HF. Community-associated meticillin-resistant Staphylococcus aureus. Lancet. 2010; 7(9): 629–641.
Udo EE, Boswihi SS. Antibiotic resistance trends in methicillin-resistant Staphylococcus aureus isolated in Kuwait hospitals: 2011-2015. Medical Principle and Practice. 2017; 26(5): 485-490.
Chen H, Liu Y, Jiang X, Chen M, Wang H. Rapid change of methicillin-resistant Staphylococcus aureus clones in a Chinese tertiary care hospital over a 15-year period. Antimicrob Agents Chemotheraphy. 2009; 54 (5): 1842-1847.
Wardenburg JB, Williams WA, Missiakas D. Host defenses against Staphylococcus aureus infection require recognition of bacterial lipoproteins. Proceedings of the National Academy of Sciences of the United States of America. 2008; 103(37): 13831–13836.
Surewaard BGJ, Deniset JF, Zemp FJ, Amrein M, Otto M, Conly J, Omri A, Yates R M, Kubes P. Identification and treatment of the Staphylococcus aureus reservoir in vivo. The Journal of Experimental Medicine. 2016; 213(7): 1141–1151.
Tadros M, Williams V, Coleman BL, McGeer AJ, Haider S, Lee C, Harris I, Rubinstein E, John M, Johnston L, McNeil S, Katz K, Laffin N, Simor A E. Epidemiology and outcome of pneumonia caused by methicillin-resistant Staphylococcus aureus (MRSA) in Canadian hospitals. MRSA Pneumonia Outcome. 2013; 8(9):1-8.
Watkins RR, David MZ, Salata RA. Current concepts on the virulence mechanisms of meticillin-resistant Staphylococcus aureus. Journal of Medical Microbiology. 2012; 61(9): 1179–1193.
Oyama T, Miyazaki M, Yoshimura M, Takata T, Ohjimi H, Jimi S. Biofilm-forming methicillin- resistant Staphylococcus aureus survive in kupffer cells and exhibit high virulence in mice. Toxins. 2016; 8(7): 1-17.
Santana H, Fábio L, Andrade A, Pereira ÍS, Miranda L, Figueiredo TB, Amaro R. Distinct strains of Staphylococcus aureus lead to different inflammatory response patterns in a murine model of intradermal infection. Acta Scientiarum. 2016; 38(4): 457–464.
Cremieux AC, Saleh-Mghir A, Danel C, Couzon F, Dumitrescu O, Lilin T, Etienne J, Vandenesc F. High frequency of panton-valentine leukocidin, impacts rabbit mortality from severe sepsis with methicillin-resistant Staphylococcus aureus osteomyelitis. Journal of Infectious Diseases.2014; 209 (11): 1773-1780.
Pasquale TR, Jabrochi B, Salstrom S, Wiemken TL, Peyrani P, Haque NZ, Scerpella EG, Ford KD, Zervous MJ, Ramirez JA, Jr TMF, IMPACT- HAP study group. Emergence of MRSA USA-300 genotype as a major cause of late-onset nosocomial pneumonia in intensive care patients in the USA. International Journal of Infectious Disease. 2013: 398-403.
Defres S, Marwick C, Nathwani D. MRSA as a cause of lung infection including airway infection, community acquired pneumonia and hospital- acquired pneumonia. European Respiratory Journal. 2009; 34(6): 1470-1476